Rigel Pharmaceuticals (RIGL) Leases: 2019-2025
Historic Leases for Rigel Pharmaceuticals (RIGL) over the last 7 years, with Sep 2025 value amounting to $1.1 million.
- Rigel Pharmaceuticals' Leases rose 159.26% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 159.26%. This contributed to the annual value of $246,000 for FY2024, which is 71.43% down from last year.
- As of Q3 2025, Rigel Pharmaceuticals' Leases stood at $1.1 million, which was down 10.87% from $1.2 million recorded in Q2 2025.
- Rigel Pharmaceuticals' 5-year Leases high stood at $15.9 million for Q1 2021, and its period low was $246,000 during Q4 2024.
- Its 3-year average for Leases is $858,636, with a median of $997,000 in 2023.
- In the last 5 years, Rigel Pharmaceuticals' Leases crashed by 85.09% in 2023 and then skyrocketed by 159.26% in 2025.
- Over the past 5 years, Rigel Pharmaceuticals' Leases (Quarterly) stood at $9.7 million in 2021, then crashed by 80.11% to $1.9 million in 2022, then slumped by 55.39% to $861,000 in 2023, then tumbled by 71.43% to $246,000 in 2024, then soared by 159.26% to $1.1 million in 2025.
- Its last three reported values are $1.1 million in Q3 2025, $1.2 million for Q2 2025, and $1.3 million during Q1 2025.